Rhode Island Hospital Emergency Department
Providence, Rhode Island, 02903, United States
NCT Number: NCT01419899
The purpose of this study is to determine if a brief intervention delivered to emergency department patients increases the uptake of rapid HIV and hepatitis C testing in comparison to no brief intervention.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Phase 2 / Phase 3
Providence, Rhode Island, 02903, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 20-30 minute motivational based discussion
Time frame: Within four hours of being consented into the study
We will measure the acceptance of free rapid testing for HIV and hepatitis C among the intervention and control groups
Time frame: Within four hours of being consented into the study
Identify factors that influence the relationship of BI and risk assessment vs. risk assessment alone on uptake of combined HIV and hepatitis C screening in the ED.
Rhode Island Hospital
Other
Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients
Acronym: InVITED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03627546
Blood-Borne Infections, Communicable Diseases
New York, United States
View Trial DetailsNCT03537196
Blood-Borne Infections, Communicable Diseases
Haiphong, Vietnam
View Trial DetailsNCT04159545
Blood-Borne Infections, Communicable Diseases
Dundee, Tayside, United Kingdom
View Trial DetailsNCT04504981
Drug Use, HIV
Los Angeles, California, United States
View Trial Details